October 9, 2017 — In an interview with Nightly Business Report, Dr. Gellad discusses his thoughts about California's drug price transparency bill, SB 17. The recently passed bill requires pharmaceutical companies to provide notification at least 60 days before prices will rise 16% over a two year period. Read More »